To evaluate the effect of ketamine S (+) 5% with no preservatives and administered as a subarachnoid single puncture on the spinal cord and meninges of rabbits.
Introduction
The initial sequence of events preceding any painful phenomenon is the transformation of aggressive stimuli into action potentials by nociceptors, which transfer the stimuli from the peripheral nerve fibres to the central nervous system 1 .
Specific pain receptors, known as nociceptors, are located in the nerve endings of the delta and C fibres, the latter of which are responsible for 70% to 80% of sensory afferent signal transduction. Nociceptors are found in superficial skin structures and the walls of the viscera and blood vessels in the musculoskeletal system; at different locations, they are capable of transmitting pain stimuli at different speeds. In addition, the nerve endings of nociceptive A delta and C fibres are able to respond to inflammatory mediators and to mechanical, thermal and chemical stimuli. Thus, such assaults on the transmission of translated electrical stimuli to the central nervous system are interpreted in the cerebral cortex as pain 2 .
The sensitisation of nociceptors occurs by decreasing their excitability threshold 3 due to the release of known antigenic chemicals that are present in the tissue environment 4 , including bradykinin, acetylcholine, prostaglandins, histamine, serotonin, substance P, leukotrienes, platelet activating factor, acid radicals, potassium ions, thromboxanes, interleukins and tumour necrosis factor 2 among others. Nociceptors can also be sensitised by noradrenergic influences from the sympathetic efferent nerves and by the retrograde release of neurotransmitters from nerve fibres 7, 8 .
In the subarachnoid route, ketamine is used to treat cancer and neuropathic pain [9] [10] [11] . Despite the present considerable clinical experience with ketamine, controversy lingers regarding the safety of ketamine administered in the subarachnoid route 12 . This is due to the potential toxicity of the agent's inclusion of preservatives (such as benzethonium chloride and chlorobutanol [13] [14] [15] ).
The aim of this study was to evaluate the effect of ketamine S (+) 5%, without preservatives and administered by an intrathecal route in a single puncture, on the spinal cord and meninges of rabbits.
Methods

After approval from the Ethics Committee on Animal
Experimentation of the Faculty of Medicine of Botucatu (Protocol 801), 20 young adult female rabbits from the breed Genetic Group Botucatu, each of which weighed between 3,500 grams and 5000 grams and had a spinal column length between 34 and 38 cm, were supplied by the animal colony of the Campus of Botucatu.
During the selection process, animals were excluded if they lacked a healthy appearance or required more than one spinal puncture. The animals were divided into two experimental groups, with 10 animals in each group. Each was subjected initially to intravenous anaesthesia with ketamine and xylazine and then to the spinal puncture. The groups differed by the type of solution administered, with group 1 (G1) receiving the volume control of saline, 0.9%, and group 2 (G2), the drug control of unpreserved ketamine S 5%.
In rabbits, the approach to the subarachnoid space between the vertebrae S1 and S2 is ample. To identify this space and to determine the site of the local spinal puncture, the iliac crests should first be palpated. Then, identifying the spinous process of the first sacral vertebra, a finger should be glided 1.5 cm to 2 cm in the caudal direction. The space of S1 -S2 is located 1 cm caudal to the spinous process of the first sacral vertebra.
Filho LJA et al. The animals were given 5 μl per centimetre of their spinal cord (0.2 ml), which was injected in 1 second using a 1 ml disposable syringe. The doses of 0.9% saline (Group 1) and 10 mg of S 5% ketamine without preservatives (G2) were synthesised by Cristália solutions.
After the injection of either solution into the spinal puncture site, the animals were removed from the operating table.
When they had recovered from intravenous anaesthesia, they were assessed clinically as to their motor blockade and soreness. Their The GFAP-stained samples embedded in paraffin were sectioned at a thickness of 3 microns on a rotary microtome for immunohistochemistry and extended onto histological glass slides previously treated with organosilane. After 18 hours in an oven at 58°C, the slides were deparaffinised with xylene, three wells at a time, after spending 5 min in each tank. Thus, the slides were placed in four tanks with absolute ethanol for 5 minutes each before their hydration in running distilled water.
Results
The statistical analysis of the figures for the weight of the animals in group 1 was lower than in group 2 (p = 0.02). There was homogeneity between the groups with respect to the length of the spine (p = 1.0) and the volume of solution administered (p = 0.67) ( Table 1) .
Group 1 Group 2
Weight (g) 3860 ± 259 4410 ± 515* Column length (cm) 36.2 ± 1.5 36.2 ± 0.6 Administered volume (ml)
1.8 ± 0.1 1.8 ± 0.03 The median percentage of cells in the control group was 42%, with quartiles at 39% and 45%; in the ketamine group, the median was 43%, with quartiles at 41% and 45% (Figure 1 ).
Effects caused by the spinal administration of ketamine S (+) 5% with no preservatives, using a single puncture, and located on the spinal cord and meninges in rabbits
Acta Cirúrgica Brasileira -Vol. 29 (7) 2014 -475 . There is evidence that microglia can directly contribute to or exacerbate neuronal degeneration 20, 21 . Therefore, the measurement of GFAP was used as an early marker of nerve injury 22 .
It has been described that repeated doses of ketamine (S) can lead to excessive NMDA receptor antagonism. This antagonism can produce neurotoxicity due to the resultant inactivation of inhibitory mechanisms (involving blockade of the NMDA receptors in the interneuronal space, as mediated by y-amino butyric acid, which is in turn responsible for the inhibition of the tonic excitatory pathways) and the cellular necrosis and apoptosis that arises after such excitotoxic lesions 23 .
In addition, prolonged NMDA receptor antagonism prevents the activation of the endogenous mechanisms for neuronal survival and regeneration 24 .
In dogs receiving a dose of 1 mg.kg -1 of 0.6 % to 1. In recent years, related experimental research has been published on rat models. These studies found ischemia of the spinal cord after the subarachnoid injection of ketamine S ( + ); this result suggests neuroprotective benefits for the treatment. It is possible that these effects could be further strengthened by combining these injections with corticosteroids in similar situations to those described above 27 .
Although the results of this study suggest that administration of a single dose of ketamine S (+) without preservatives in the subarachnoid space of rabbits does not trigger lesions in the spinal nerve tissue and meninges, there is no consensus on this topic. Therefore, further studies are needed to elucidate this issue.
Conclusion
This rabbit experimental model of ketamine S (+) 5%, with no preservatives and administered in the subarachnoid space in a single dose, did not induce histological changes within the nervous tissue or the meninges.
